Organon (OGN) Share-based Compensation (2020 - 2026)

Organon's Share-based Compensation history runs 7 years deep, the most recent figure standing at $19.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 20.83% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $72.0 million (down 30.1% YoY), while the FY2025 annual figure was $77.0 million, down 26.67% from the prior year.
• Share-based Compensation was $19.0 million for Q1 2026 at Organon, up from $7.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $28.0 million in Q2 2024 to a low of $7.0 million in Q4 2025.
• Historically, Share-based Compensation has averaged $22.2 million across 5 years, with a median of $24.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 53.33% in 2022, then plunged 73.08% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $23.0 million in 2022, then advanced by 17.39% to $27.0 million in 2023, then fell by 3.7% to $26.0 million in 2024, then tumbled by 73.08% to $7.0 million in 2025, then soared by 171.43% to $19.0 million in 2026.
• The last three Share-based Compensation figures came in at $19.0 million (Q1 2026), $7.0 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.